1st GetReal Institute Annual Conference: Deep dive into Session 2 – can real-world evidence bring back drug development to Europe? 

Written by Joanne Walker

In the second session looking at real-world evidence (RWE) in Europe, Andrew Roddam (Our Future Health, UK) welcomed the panellists: Rick Grobbee (UMC Utrecht), Francois Houyez (EURORDIS), Iris Goetz (Eli Lilly) and Tim Williams (CPRD). The session looked at drug development in Europe, with the aim of answering the question ‘Pragmatic trials and historical controls, why not use RWE?’  Jump to: What is the current landscape in Europe? Are there opportunities for Europe to use RWE and lead the way for this type of evidence generation in the future? What lessons can be learned from how clinical trials were carried...

To view this content, please register now for access

It's completely free